Join Executive Women In Bio to hear a conversation about how empowered women, empower women. (More details coming soon!)
Note: This event is open to the general public (a BIO pass is not required to attend). It may be recorded. If so, there is a possibility your image and or voice may be a part of that recording. If you do not wish for your image to be included, please turn off your camera.
Amanda Hindlian, Global Head of Markets for the NYSE
Cathy Sohn, Board Director, Chairman of BioEclipse Therapeutics, Former SrVP at GSK, Adjunct Professor at UCSF
Catherine Angell Sohn, PharmD is an experienced biopharmaceutical executive and private and public company Board director with expertise in strategy, strategic product development, business development, commercialization of new medicines and vaccines, and public company Board governance.
Dr. Sohn is currently chairman of BioEclipse Therapeutics, a privately held, clinical-stage oncology company and is an independent Director on the Board of Directors of Jazz Pharmaceuticals plc (NASDAQ: JAZZ), Rubius Therapeutics (NASDAQ: RUBY), Axcella Health (NASDAQ: AXLA), Landec Corp (NASDAQ: LNDC) and Maze Therapeutics (privately held). She is Chair of the Compensation Committees at RUBY and serves on the Compensation Committee at JAZZ, AXLA, and Maze. Sohn is Chair the Nom/Gov Committee at AXLA and Maze, serves on the Nom/Gov committee at JAZZ, and serves on the Audit Committees of RUBY and LNDC. Dr. Sohn also particularly enjoys engaging with students as Adjunct Professor at the University of California, San Francisco, her alma mater.
Click here for Cathy’s full bio.
- Members: Free
- Non-Members*: $30
- Optional Donation: $10
*To access the Member rate, please click here to purchase a WIB membership. Please enter the code Becomeamemberandsave to save $10 off membership. This code is valid through July 31, 2021.
Note: Zoom meeting link will be sent along with confirmation email, after registration has been completed.